Evidence map›Paper›PMID 31988379›Full record

ArticleNature microbiology2020

Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth.

Elena Zagato, Chiara Pozzi, Alice Bertocchi, Tiziana Schioppa, Fabiana Saccheri, Silvia Guglietta, Bruno Fosso, Laura Melocchi, Giulia Nizzoli, Jacopo Troisi and 15 more

Open access · greenAbstract read
In one paragraph

Article in Nature microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 278 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
278citing papers in PubMed, 1 pooled it
21.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

278 citing papers in PubMed, 1 synthesis or guideline pooled it, 486 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Sulforaphane-ProducingFood science & nutrition · 2026
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Efavirenz-Altered Gut-Microbiota,International journal of molecular sciences · 2026
    Article
  19. Review
  20. Article

218 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 13 institutions in 4 countries.

Elena Zagato *Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.ORCID http://orcid.org/0000-0001-6756-3674
Chiara Pozzi *Humanitas Clinical and Research Center, IRCCS, Milan, Italy.ORCID http://orcid.org/0000-0003-2153-6130
Alice BertocchiHumanitas Clinical and Research Center, IRCCS, Milan, Italy.
Tiziana SchioppaDepartment of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
Fabiana SaccheriDepartment of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.
Silvia GugliettaDepartment of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.ORCID http://orcid.org/0000-0001-9998-5716
Bruno FossoInstitute of Biomembranes, Bioenergetics and Molecular Biotechnologies, Consiglio Nazionale delle Ricerche, Bari, Italy.ORCID http://orcid.org/0000-0003-2324-086X
Laura MelocchiSection of Pathology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
Giulia NizzoliGastroenterology and Endoscopy Unit, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Jacopo TroisiDepartment of Medicine, Surgery and Dentistry, Scuola Medica Salernitana, University of Salerno, Baronissi, SA, Italy.ORCID http://orcid.org/0000-0003-2962-7379
Marinella MarzanoInstitute of Biomembranes, Bioenergetics and Molecular Biotechnologies, Consiglio Nazionale delle Ricerche, Bari, Italy.
Bianca OrestaHumanitas Clinical and Research Center, IRCCS, Milan, Italy.
Ilaria SpadoniDepartment of Biomedical Sciences, Humanitas University, Milan, Italy.
Koji AtarashiRIKEN Center for Integrative Medical Sciences, Tsurumi-ku, Yokohama, Japan.ORCID http://orcid.org/0000-0001-5422-0736
Sara CarloniDepartment of Biomedical Sciences, Humanitas University, Milan, Italy.ORCID http://orcid.org/0000-0002-3673-7026
Stefania ArioliDivision of Food Microbiology and Bioprocesses and Department of Food, Environmental and Nutritional Sciences, Università degli Studi di Milano, Milan, Italy.ORCID http://orcid.org/0000-0002-5406-8268
Giulia FornasaHumanitas Clinical and Research Center, IRCCS, Milan, Italy.
Francesco AsnicarCIBIO Department, University of Trento, Trento, Italy.ORCID http://orcid.org/0000-0003-3732-1468
Nicola SegataCIBIO Department, University of Trento, Trento, Italy.ORCID http://orcid.org/0000-0002-1583-5794
Simone GuglielmettiDivision of Food Microbiology and Bioprocesses and Department of Food, Environmental and Nutritional Sciences, Università degli Studi di Milano, Milan, Italy.ORCID http://orcid.org/0000-0002-8673-8190
Kenya HondaRIKEN Center for Integrative Medical Sciences, Tsurumi-ku, Yokohama, Japan.ORCID http://orcid.org/0000-0001-8937-9835
Graziano PesoleInstitute of Biomembranes, Bioenergetics and Molecular Biotechnologies, Consiglio Nazionale delle Ricerche, Bari, Italy.ORCID http://orcid.org/0000-0003-3663-0859
William VermiSection of Pathology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
Giuseppe PennaHumanitas Clinical and Research Center, IRCCS, Milan, Italy.
Maria RescignoHumanitas Clinical and Research Center, IRCCS, Milan, Italy. maria.rescigno@hunimed.eu.ORCID http://orcid.org/0000-0002-6464-509X
Humanitas University · ITInstitute of Biomembranes, Bioenergetics and Molecular Biotechnologies · ITKeio University · JPUniversity of Milan · ITUniversity of Trento · ITEuropean Institute of Oncology · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITFondazione Poliambulanza Istituto Ospedaliero · ITInstitute of Oncology Research · CHMedical University of South Carolina · USUniversity of Brescia · ITUniversity of Salerno · ITWashington University in St. Louis · US

Funding

European Research Council 615735
6 · The paper itself

Abstract

The microbiota has been shown to promote intestinal tumourigenesis, but a possible anti-tumourigenic effect has also been postulated. Here, we demonstrate that changes in the microbiota and mucus composition are concomitant with tumourigenesis. We identified two anti-tumourigenic strains of the microbiota-Faecalibaculum rodentium and its human homologue, Holdemanella biformis-that are strongly under-represented during tumourigenesis. Reconstitution of Apc

Indexed as

AdultAgedAnimalsBacillotaCell ProliferationColonic NeoplasmsDNA, BacterialFatty Acids, VolatileFemaleGastrointestinal MicrobiomeHumansIn Situ Hybridization, FluorescenceIntestinal NeoplasmsIntestinesMaleMiceDNA, BacterialFatty Acids, VolatileRNA, Bacterial

Identifiers

PMID31988379
PMCPMC7048616
OpenAlexW3001680293

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.